Myomo MYO
NYSE MYO
$1.73 -0.01 (-0.57%)
At close: Aug 21, 2026 · 4:00 PM EDT

Myomo (MYO) Liabilities and Shareholders Equity (2016 - 2025)

Myomo's (MYO) quarterly Liabilities and Shareholders Equity came in at $38.6 million in Q4 2025, down 8.54% YoY from $42.2 million in Q4 2024, and up 13.38% on a QoQ basis from $34.1 million in Q3 2025.

Myomo (MYO) Liabilities and Shareholders Equity (2016 - 2025) Analysis & Trends

Myomo (MYO) has 10 years of Liabilities and Shareholders Equity data on file, last reported at $38.6 million in Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 8.54% year-over-year to $38.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $152.3 million (up 66.82% YoY) and the FY2025 annual result came in at $38.6 million, down 8.54% from the prior year.
  • Liabilities and Shareholders Equity climbed to $38.6 million in Q4 2025, from $34.1 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $42.2 million in Q4 2024 to a low of $10.2 million in Q4 2022.
  • A 5-year average of $21.7 million and a median of $17.3 million in 2021 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity slumped 49.43% — and 2024, when it surged 189.71%.
  • Tracing MYO's Liabilities and Shareholders Equity over 5 years: stood at $20.1 million in 2021, then tumbled by 49.43% to $10.2 million in 2022, then jumped by 43.49% to $14.6 million in 2023, then surged by 189.71% to $42.2 million in 2024, then decreased by 8.54% to $38.6 million in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $38.6 million (Q4 2025), $34.1 million (Q3 2025), and $38.7 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn 109.22 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 47.93 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn 13.87 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 31.04 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 10.74 Bn
10 Myomo 67.26 Mn 48.29 Mn - 38.64 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 38.64 Mn
Sep 30, 2025 34.08 Mn
Jun 30, 2025 38.67 Mn
Mar 31, 2025 40.87 Mn
Dec 31, 2024 42.24 Mn
Sep 30, 2024 16.31 Mn
Jun 30, 2024 16.19 Mn
Mar 31, 2024 16.52 Mn
Dec 31, 2023 14.58 Mn
Sep 30, 2023 17.05 Mn
Jun 30, 2023 13.30 Mn
Mar 31, 2023 13.74 Mn
Dec 31, 2022 10.16 Mn
Sep 30, 2022 12.16 Mn
Jun 30, 2022 14.56 Mn
Mar 31, 2022 17.98 Mn
Dec 31, 2021 20.10 Mn
Sep 30, 2021 17.46 Mn
Jun 30, 2021 17.71 Mn
Mar 31, 2021 20.92 Mn